This paper is in the following e-collection/theme issue:

Pharmacovigilance (171) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (215) Natural Language Processing (917) Prevention and Health Promotion (1362) Artificial Intelligence (2129)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40080, first published .
Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review

Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review

Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review

Authors of this article:

Joel Fossouo Tagne1, 2, 3 Author Orcid Image ;   Reginald Amin Yakob4 Author Orcid Image ;   Thu Ha Dang5, 6 Author Orcid Image ;   Rachael Mcdonald3, 7, 8 Author Orcid Image ;   Nilmini Wickramasinghe1, 8, 9 Author Orcid Image
Article Authors Cited by (25) Tweetations (4) Metrics

Journals

  1. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy. JMIR Human Factors 2023;10:e43529 View
  2. Valinciute A, Gerbutaviciene R, Paukstaitiene R, Kubiliene L. Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study. Healthcare 2023;11(8):1133 View
  3. Mhaidat N, Alshogran O, Altawalbeh S, Jaber J, Banat H, Ahmad D, Alabsi W. Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015–2021). Expert Opinion on Drug Safety 2023;22(10):957 View
  4. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacists in Australia: Usability Testing Study. JMIR Formative Research 2023;7:e48976 View
  5. Liao J, Zhan Y, Zhang Z, Cui J, Yin J. HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature. Frontiers in Pharmacology 2023;14 View
  6. Chen W, Li S, Huang D, Su Y. Drugs associated with a risk of supraventricular tachycardia: analysis using the OpenVigil database. Journal of International Medical Research 2024;52(3) View
  7. Lin S, Lei S, Liu W, Zhu X, Yin L, Liu Q, Feng B. Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study. International Journal of Clinical Pharmacy 2024;46(5):1076 View
  8. Selva P, Durairajan S. Exploration and Evaluation of Adverse Drug Reactions Documented in a Tertiary-Care Hospital in Chennai: An In-Depth Retrospective Observational Study. Cureus 2024 View
  9. Mulkalwar S, Chitale S, Dandage P, Bapat S, Tilak A, Patil S. Evaluation of the Effectiveness of the Adverse Drug Reaction Alert Card System in Preventing the Recurrence of Adverse Drug Reactions. Cureus 2024 View
  10. Cheng W, Du J, Chen C, Cao J, Xia X, Yang X, Zhang W, Jia X, Qi Y. Exploring the influencing factors of adverse drug reaction reporting among medical personnel: a COM-B model-based study. Journal of Pharmaceutical Policy and Practice 2024;17(1) View
  11. Deutscher B, De Guzman K, La Caze A, Falconer N. A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting. Expert Review of Clinical Pharmacology 2024;17(12):1127 View
  12. Gebreyohannes E, Thornton C, Thiessen M, de Vries S, Q Andrade A, Kalisch Ellett L, Frank O, Cheah P, Choo K, Laba T, Roughead E, Hwang I, Moses G, Lim R. Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project). JMIR Research Protocols 2025;14:e60084 View
  13. Rekha B, Hisham S, Wahab I, Ali N, Goh K, Ming L. Digital monitoring of medication safety in children: an investigation of ADR signalling techniques in Malaysia. BMC Medical Informatics and Decision Making 2024;24(1) View
  14. Petrović N, Pejčić A, Milosavljević M, Janković S. Risk factors for severe adverse drug reactions in hospitalized patients. Open Medicine 2025;20(1) View
  15. Coleman M, Mari W. An early Web history of vaccine skeptical digital rhetorics. Internet Histories 2025;9(3):229 View
  16. Khalil A, Gaol F, Sabarguna B, Prabowo H. A holistic platform for adverse drug reaction prevention and monitoring: leveraging service-oriented architecture for tailored healthcare solutions. Service Oriented Computing and Applications 2025 View
  17. Eshetie Y, Aytenew T, Abere Y, Belay B, Amera T, Ewunetu M, Yirga G, Tesfahun Y, Kebede M, Kefale D, Belayneh Z. Prevalence and its associated factors of medical error reporting among healthcare professionals in Ethiopia: Systematic review and meta-analysis. PLOS One 2025;20(6):e0325114 View
  18. Yagudina R, Listova O, Umerova A, Kopeyka K. Analysis of pharmacy organisation staff awareness of pharmacovigilance. Pharmacy & Pharmacology 2025;12(4):266 View
  19. AlRasheed M, AlHawas S, AlOrf N, AlFadel N, AlHarbi F. Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase. Therapeutic Innovation & Regulatory Science 2025;59(6):1432 View
  20. Pei Y, Huang R, Chang F, Hu Y, Versteeg S, Zheng Y. The Role of Pharmacists in Delivering Pharmaceutical Services to Breast Cancer Patients in Clinical and Community Settings: A Scoping Review. Pharmacy 2025;13(4):97 View
  21. Mo X, Liang G, Gan W, Xu L, Yan M. Fatal anaphylactic shock following cefoperazone–sulbactam re-exposure: a short report on systemic gaps in adverse drug reaction management. BMJ Open Quality 2025;14(3):e003392 View
  22. Fossouo Tagne J, Yakob R, McDonald R, Wickramasinghe N. Designing for the system, not just the user: a structured systems thinking approach to aligning pharmacy innovations with complex healthcare systems. International Journal of Pharmacy Practice 2025 View
  23. Saputri I. Farmakovogilans Berbasis Fasilitas Kesehatan: Peran Apoteker Klinis dalam Pelaporan Kejadian Obat yang Tidak Diinginkan. Sciences and Clinical Pharmacy Research Journal 2025;2(3):12 View
  24. Sayali Dadasaheb Kardile , Ganesh Balasaheb Jiwade , Madhuri Sanjay Wabale , Samruddhi Subhash Adsul , Vaishnavi Sanjay Ugale . Review on Adverse Drug Reaction Reporting. International Journal of Advanced Research in Science Communication and Technology 2025:246 View

Books/Policy Documents

  1. Bektay M, Sancar M. The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings. View